SCHEMBL7786937

SCHEMBL7786937

CSc1ccc(/C(C#N)=N\OS(=O)(=O)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MAPK1 P28482 3/20 0.37
KDM4E B2RXH2 2/20 0.37
NR2F2 P24468 1/20 0.37
GALR3 O60755 1/20 0.36
CDK2 P24941 1/20 0.36
F2 P00734 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 2/20 0.35
MITF O75030 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786939 1.00 MAPT (0.46) MAPTALDH1A1POLBSMN1; SMN2NPC1
SCHEMBL2582376 0.86 ALDH1A1 (0.41) MAPTALDH1A1SMN1; SMN2RAB9AMAPK1
SCHEMBL2582375 0.86 ALDH1A1 (0.41) MAPTALDH1A1SMN1; SMN2RAB9AMAPK1
SCHEMBL28486532 0.85 MAPT (0.50) MAPTALDH1A1POLBSMN1; SMN2NPC1
SCHEMBL7789208 0.85 MAPT (0.43) MAPTALDH1A1SMN1; SMN2NPC1MAPK1
SCHEMBL7789209 0.85 MAPT (0.43) MAPTALDH1A1SMN1; SMN2NPC1MAPK1
SCHEMBL36277 0.84 MAPT (0.51) MAPTALDH1A1POLBSMN1; SMN2NPC1
SCHEMBL36278 0.84 MAPT (0.51) MAPTALDH1A1POLBSMN1; SMN2NPC1
SCHEMBL14839200 0.82 ALDH1A1 (0.40) MAPTALDH1A1POLBSMN1; SMN2MEN1
SCHEMBL7786450 0.80 MAPT (0.50) MAPTALDH1A1POLBSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US claimed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH MAPT 4475/4885ALDH1A1 160/4885POLB 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.